Research Papers:
Prognostic values of tissue factor and its alternatively splice transcripts in human gastric cancer tissues
Metrics: PDF 1539 views | HTML 1975 views | ?
Abstract
Min Wu1,2,3,*, Lujun Chen1,2,4,*, Ting Xu1,2,3,*, Bin Xu1,2,4, Jingting Jiang1,2,4 and Changping Wu1,2,4,5
1Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China
2Research Center for Cancer Immunotherapy of Jiangsu Province, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China
3Department of Rheumatology, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China
4Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China
5Department of Oncology, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China
*These authors have contributed equally to this work
Correspondence to:
Jingting Jiang, email: [email protected]
Changping Wu, email: [email protected]
Keywords: gastric cancer, tissue factor, alternative splice, prognosis
Received: September 26, 2016 Accepted: February 21, 2017 Published: May 16, 2017
ABSTRACT
We have previously reported that the higher expression of TF in human esophageal cancer tissues was significantly associated with tumor invasion, intratumoral microvessel density and patients’ postoperative prognoses. Besides its trans-membranous form, TF also has alternatively spliced transcripts. In the present study, the transcripts of the two TF isoforms, flTF and asTF, in human gastric cancer tissues were determined by real-time PCR, and the correlation between the expression of TF isoforms and patient’s clinicopathological features was also analyzed. Our results showed that the relative mRNA expression levels of flTF and asTF in human gastric cancer tissues was significantly higher than those in normal tissues (P=0.035 and P=0.006, respectively). The relative mRNA expression level of asTF was significantly associated with age (P=0.018), meanwhile, we could not find that flTF or asTF expression level was correlated with any other characteristics of the patients, including gender, TNM stage, pathological grade, tumor size, histological type, or chemotherapy sensitivity. Univariate analysis demonstrated that the overall survival rate of gastric cancer patients with lower flTF or asTF expression level was greater than those with higher expression level (P=0.018 and =0.038, respectively). Multivariate COX model analysis also demonstrated that flTF expression (P=0.048) or asTF expression (P=0.002) could be used as independent prognostic predictors in human gastric cancer. Thus, both flTF and asTF mRNA expression levels in cancer tissues could be used as useful risk factors for evaluating the prognoses of patients suffering from gastric cancer.

PII: 17942